EMG
BDSI

Ellington Management Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Ellington Management Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,500
Closed -$66K – 890
2019
Q1 		$66K Buy
+12,500
New +$57.1K 0.01% 544
2015
Q3 		– Sell
-22,997
Closed -$183K – 1066
2015
Q2 		$183K Buy
+22,997
New +$198K 0.04% 607
2014
Q3 		– Sell
-42,100
Closed -$508K – 602
2014
Q2 		$508K Buy
+42,100
New +$399K 0.24% 114

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ellington Management Group's BDSI Position: Q2 2019 in Review

Ellington Management Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2019, closing a stake of 12,500 shares — an estimated $66K sold.

Ellington Management Group first reported a position in BDSI in Q2 2014 and held it in 3 quarters. The position peaked at $508K in Q2 2014. 110 funds tracked by Wall St. Rank hold BDSI as of Q2 2019.

  • Ellington Management Group reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2019 after selling out during the quarter.
  • Ellington Management Group sold 12,500 BioDelivery Sciences International, Inc. shares in Q2 2019, an estimated $66K.
  • Ellington Management Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 3 quarters.
  • Ellington Management Group's BioDelivery Sciences International, Inc. position peaked at $508K in Q2 2014.
  • 110 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.